Toggle light / dark theme

The synthesis of plastic precursors, such as polymers, involves specialized catalysts. However, the traditional batch-based method of finding and screening the right ones for a given result consumes liters of solvent, generates large quantities of chemical waste, and is an expensive, time-consuming process involving multiple trials.

Ryan Hartman, professor of chemical and at the NYU Tandon School of Engineering, and his laboratory developed a lab-based “intelligent microsystem” employing , for modeling that shows promise for eliminating this costly process and minimizing environmental harm.

In their research, “Combining automated microfluidic experimentation with machine learning for efficient polymerization design,” published in Nature Machine Intelligence, the collaborators, including doctoral student Benjamin Rizkin, employed a custom-designed, rapidly prototyped microreactor in conjunction with automation and in situ infrared thermography to study exothermic (heat generating) polymerization—reactions that are notoriously difficult to control when limited experimental kinetic data are available. By pairing efficient microfluidic technology with machine learning algorithms to obtain high-fidelity datasets based on minimal iterations, they were able to reduce chemical waste by two orders of magnitude and catalytic discovery from weeks to hours.

https://www.youtube.com/watch?v=r-vbh3t7WVI

Your Neuralink device would be implanted using traditional neurosurgery methods safely and seamlessly with a robot surgeon. As mentioned in the Neuralink published paper, “We have also built a neurosurgical robot capable of inserting six threads (192 electrodes) per minute. Each thread can be individually inserted into the brain with micron precision for the avoidance of surface vasculature and targeting specific brain regions.”

The Neuralink team has already started experimenting with various versions of the devices on both rats and monkeys. The results have been impressive. During the presentation in San Francisco, Musk and his team described one instance of a monkey being able to control a computer with simply its brain. Unfortunately, (or fortunately) there have not been any tests on humans. Yet, the team hopes to obtain FDA approval and begin human trials as early as this year.

During his presentation Elon Musk reiterated the idea that Neuralink will be an important part of our future, eventually allowing us to reach symbiosis with artificial intelligence. “With a high bandwidth brain-machine interface, we can go along for the ride and effectively have the option of merging with AI”, said Musk. And as for the risks to reach this end goal? Musk reassured his audience that the device will be safe.

Most of the pieces of Elon Musk’s Master Plan, Part Deux are already in place. Tesla’s mass-market cars, the Model 3 and Model Y, have already been released. The Solar Roof is finally seeing a ramp. And the release of a feature-complete version of the company’s Full Self-Driving suite seems to be drawing closer.

For Tesla’s Full Self-Driving suite to be feature-complete, the electric car maker would need to master inner-city driving. FSD already works for highway driving with Navigate on Autopilot with automatic lane changes. But when it comes to inner-city streets, Full Self-Driving still has some ways to go. Fortunately, if Tesla’s v10.2 2020.12.5 release is any indication, it appears that more and more aspects of city driving are becoming recognized by the company’s neural networks.

The role of automatic electrocardiogram (ECG) analysis in clinical practice is limited by the accuracy of existing models. Deep Neural Networks (DNNs) are models composed of stacked transformations that learn tasks by examples. This technology has recently achieved striking success in a variety of task and there are great expectations on how it might improve clinical practice. Here we present a DNN model trained in a dataset with more than 2 million labeled exams analyzed by the Telehealth Network of Minas Gerais and collected under the scope of the CODE (Clinical Outcomes in Digital Electrocardiology) study. The DNN outperform cardiology resident medical doctors in recognizing 6 types of abnormalities in 12-lead ECG recordings, with F1 scores above 80% and specificity over 99%. These results indicate ECG analysis based on DNNs, previously studied in a single-lead setup, generalizes well to 12-lead exams, taking the technology closer to the standard clinical practice.

The Ancient History of AI:


This video was made possible by Surfshark. Sign up with this link and enter the promo code ‘Futurology’ to get 83% off and an extra month free of your VPN plan! https://surfshark.deals/Futurology

Artificial intelligence has been a topic of growing prominence in the media and mainstream culture since 2015, as well as in the investment world, with start-ups that even mention the word in their business model, gaining massive amounts of funding.

Researchers at the Hebrew University of Jerusalem announced on Sunday that they have developed a new method of testing for COVID-19 which is not only 4–10 times faster than the tests most commonly used today, but also significantly cheaper, while supplying the same level of accuracy. Moreover, most of the materials required to perform the new test are already available in Israel, easing significantly both the country’s dire shortage of testing materials and its heavy economic dependence on foreign commercial markets. The method was developed in the labs of Prof. Nir Friedman of the Institute of Life Sciences and the School of Engineering and Computer Sciences and Dr. Naomi Haviv of Hebrew University’s Neuroscience Research Center, and is based on materials which are not affected by global shortages and can be recycled for repeated used on future tests. The method commonly used today for COVID-19 testing involves extracting RNA molecules from a patient’s sample to determine if the molecules produced have viral RNA within them, which confirms the presence of the coronavirus. The new test developed by the researchers performs the same action, but is made from more commonly attainable materials, that produce results at a much higher speed. Dr. Naomi Haviv said that “We have an efficient RNA extraction method, 4–10 times faster than the current method. It is based on magnetic beads and can be performed both robotically and manually.”

Other than the magnetic beads, all of the other materials needed to perform the tests are available for purchase in Israel. The beads themselves are recyclable and can be reused to perform future tests. “The robotic method has already undergone a series of tests at Hadassah Hospital, using hundreds of samples from patients — and is now becoming operational.”


The new test would supply results 4–10 times faster than the current method, and is made almost entirely from materials which are easily available for purchase within the country.

It is a common misconception that quantum computers are not yet ready for applications and the technology still has many years before becoming useful. In this article we will take a look at some of the basic principles of programming a quantum computer and address this misconception. We will look at free, open-source software such as QISKit from IBM, as well as the Quantum Machine Learning software PennyLane. We will also explain how you can run your programs on actual quantum computers in the cloud at IBM. In a follow-up article we will talk about some applications in machine learning that are ready for use currently to anyone with a bit of curiosity.